The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A large retrospective analysis of trabectedin in 885 patients with advanced soft tissue sarcoma.
Axel Le Cesne
Honoraria - Novartis; Pfizer; PharmaMar
Isabelle Ray-Coquard
Honoraria - Novartis; PharmaMar; Roche
Florence Duffaud
Honoraria - GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Christine Chevreau
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose
Binh Bui
No relevant relationships to disclose
Sophie Piperno-Neumann
No relevant relationships to disclose
Corinne Delcambre
No relevant relationships to disclose
Maria Rios
No relevant relationships to disclose
Loic Chaigneau
No relevant relationships to disclose
Christine Le Maignan
No relevant relationships to disclose
Cecile Guillemet
No relevant relationships to disclose
François Bertucci
No relevant relationships to disclose
Emmanuelle Bompas
No relevant relationships to disclose
Claude Linassier
No relevant relationships to disclose
Olivier Collard
No relevant relationships to disclose
Caroline Even
No relevant relationships to disclose
Francoise Ducimetiere
No relevant relationships to disclose
Philippe Cousin
No relevant relationships to disclose
Jean-Yves Blay
Consultant or Advisory Role - GlaxoSmithKline; Novartis
Honoraria - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche